SC
AMGN icon

Stance Capital’s Amgen AMGN Stock Holding History

Stance Capital’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.31M Sell
3,718
-680
-15% -$242K 0.63% 74
2025
Q4 		$1.44M Sell
4,398
-1,332
-23% -$423K 0.53% 54
2025
Q3 		$1.62M Buy
5,730
+1,267
+28% +$367K 0.59% 40
2025
Q2 		$1.25M Buy
+4,463
New +$1.26M 0.47% 132
2025
Q1 		– Sell
-13,095
Closed -$3.41M – 58
2024
Q4 		$3.41M Buy
+13,095
New +$3.89M 2.11% 27

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Stance Capital's AMGN Position: Q1 2026 in Review

Stance Capital reduced its Amgen (AMGN) stake by 15% in Q1 2026, selling an estimated $242K and leaving 3,718 shares worth $1.31M. The position accounts for 0.63% of the portfolio, ranked #74.

Stance Capital first reported a position in AMGN in Q4 2024 and has held it in 5 quarters since. The position peaked at $3.41M in Q4 2024. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Stance Capital held 3,718 shares of Amgen worth $1.31M as of Q1 2026.
  • Stance Capital sold 680 Amgen shares in Q1 2026, an estimated $242K.
  • Amgen made up 0.63% of Stance Capital's portfolio in Q1 2026, its #74 holding.
  • Stance Capital first reported a position in Amgen in Q4 2024 and has held it in 5 quarters since.
  • Stance Capital's Amgen position peaked at $3.41M in Q4 2024.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Stance Capital's 13F filing for Q1 2026, filed 14 May 2026.